• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.

作者信息

Tattersall M H, Ganeshaguru K, Hoffbrand A V

出版信息

Br J Haematol. 1974 May;27(1):39-46. doi: 10.1111/j.1365-2141.1974.tb06772.x.

DOI:10.1111/j.1365-2141.1974.tb06772.x
PMID:4368900
Abstract
摘要

相似文献

1
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.人急性白血病细胞对阿糖胞苷耐药的机制
Br J Haematol. 1974 May;27(1):39-46. doi: 10.1111/j.1365-2141.1974.tb06772.x.
2
Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
Ann N Y Acad Sci. 1975 Aug 8;255:247-51. doi: 10.1111/j.1749-6632.1975.tb29231.x.
3
Cytidine deaminase and the development of resistance to arabinosyl cytosine.胞苷脱氨酶与对阿糖胞苷耐药性的产生
Nat New Biol. 1971 Sep 22;233(38):109-10. doi: 10.1038/newbio233109a0.
4
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
Clin Sci (Lond). 1981 Feb;60(2):191-8. doi: 10.1042/cs0600191.
5
Correlation of cytosine arabinoside-induced increment in growth fraction of leukemic blast cells with clinical response.阿糖胞苷诱导白血病原始细胞生长分数增加与临床反应的相关性。
Cancer. 1974 Mar;33(3):603-10. doi: 10.1002/1097-0142(197403)33:3<603::aid-cncr2820330302>3.0.co;2-s.
6
Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.急性非淋巴细胞白血病对“大剂量”阿糖胞苷治疗反应的预测
Br J Haematol. 1985 Apr;59(4):733-4. doi: 10.1111/j.1365-2141.1985.tb07372.x.
7
Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside.阿糖胞苷对人白血病原粒细胞体内细胞周期的干扰
Scand J Haematol. 1973;10(3):209-18. doi: 10.1111/j.1600-0609.1973.tb00062.x.
8
In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.
Semin Oncol. 1987 Jun;14(2 Suppl 1):231-7.
9
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.脱氧胞苷激酶在缺氧条件下表达下调，并赋予急性髓系白血病对阿糖胞苷的耐药性。
Eur J Haematol. 2016 Sep;97(3):239-44. doi: 10.1111/ejh.12711. Epub 2015 Dec 28.
10
Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse.
Cancer Res. 1973 Nov;33(11):2816-20.

引用本文的文献

1
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.白血病和淋巴瘤中阿糖胞苷治疗的反应与毒性：从剂量难题到药物基因组生物标志物
Cancers (Basel). 2021 Feb 25;13(5):966. doi: 10.3390/cancers13050966.
2
Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.创建抗zebularine的人胞苷脱氨酶突变体以增强造血干细胞的化学保护作用。
Protein Eng Des Sel. 2016 Dec;29(12):573-582. doi: 10.1093/protein/gzw012. Epub 2016 May 8.
3
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.
核苷酸代谢酶在骨髓增生异常综合征中的表达及其对阿扎胞苷反应的调节。
Leukemia. 2014 Mar;28(3):621-8. doi: 10.1038/leu.2013.330. Epub 2013 Nov 6.
4
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.RRM1 和 RRM2 药物遗传学：与 HapMap 细胞系和急性髓系白血病患者表型的关联。
Pharmacogenomics. 2013 Sep;14(12):1449-66. doi: 10.2217/pgs.13.131.
5
The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.急性髓细胞白血病中具有临床相关性的药物基因组学改变。
Pharmacogenomics. 2012 Aug;13(11):1257-69. doi: 10.2217/pgs.12.102.
6
Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.骨髓基质细胞调节小鼠 ENT1 活性并保护白血病细胞免受阿糖胞苷诱导的凋亡。
PLoS One. 2012;7(5):e37203. doi: 10.1371/journal.pone.0037203. Epub 2012 May 22.
7
Genetic factors influencing cytarabine therapy.影响阿糖胞苷治疗的遗传因素。
Pharmacogenomics. 2009 Oct;10(10):1657-74. doi: 10.2217/pgs.09.118.
8
Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.对阿糖胞苷的耐药性诱导NKG2D配体上调，并增强自然杀伤细胞对白血病细胞的裂解作用。
Neoplasia. 2008 Dec;10(12):1402-10. doi: 10.1593/neo.08972.
9
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.急性髓细胞白血病患儿的胞苷脱氨酶基因型与阿糖胞苷治疗的毒性
Br J Haematol. 2009 Feb;144(3):388-94. doi: 10.1111/j.1365-2141.2008.07461.x. Epub 2008 Nov 22.
10
Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.胞苷脱氨酶启动子中功能性单核苷酸多态性单倍型的鉴定。
Hum Genet. 2006 Apr;119(3):276-83. doi: 10.1007/s00439-006-0142-0. Epub 2006 Jan 31.